Trial Outcomes & Findings for The COPENHAGEN Puberty Study (NCT NCT01411527)

NCT ID: NCT01411527

Last Updated: 2019-10-10

Results Overview

Pubertal onset (according to Tanner stageing - Marshall \& Tanner 1969 and 1970), i.e. Tanner stages B2+ or G2+ \[Tanner stages included genital stages 1-5 as well as pubic hairs tages 1-6\] Data of both arms were pooled for calculation of means.

Recruitment status

COMPLETED

Target enrollment

1957 participants

Primary outcome timeframe

up to 8 year period.

Results posted on

2019-10-10

Participant Flow

Cross-sectional study: All pupils at 10 different schools in the Copenhagen area were invited to participate. Longitudinal study: All pupils from 2 of the 10 schools were invited to participate in the follow up study. This includes pupils that have been recruited to the cross-sectional part. (see footnote)

No participants were excluded

Participant milestones

Participant milestones
Measure
Cross- Sectional Cohort
Schools were randomly selected. Blood samples were drawn, and a thorough clinical examination was performed in all participating children
Longitudinal Cohort
Healthy Danish children were examined and blood samples were drawn every 6 months.
Overall Study
STARTED
1864
93
Overall Study
COMPLETED
1864
93
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The COPENHAGEN Puberty Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cross- Sectional Cohort
n=1748 Participants
Schools were randomly selected and 6203 children (50.0 % girls) were invited to participate. 1864 (1097 girls and 767 boys) (age 5.6-20.0 years) were included, resulting in an overall participation-rate of 30%. Blood samples were drawn, and a thorough clinical examination was performed in all participating children
Longitudinal Cohort
n=209 Participants
209 healthy Danish children (108 girls), were examined and blood samples were drawn every 6 months. In july 2011, the mean (range) number of examinations per child was 7 (2-10). 116 (63 boys and 53 girls) continued from the cross sectional study to the longitudinal study.
Total
n=1957 Participants
Total of all reporting groups
Age, Categorical
<=18 years
1748 Participants
n=99 Participants
209 Participants
n=107 Participants
1957 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Continuous
11.8 years
n=99 Participants
11.8 years
n=107 Participants
11.8 years
n=206 Participants
Sex: Female, Male
Female
1044 Participants
n=99 Participants
108 Participants
n=107 Participants
1152 Participants
n=206 Participants
Sex: Female, Male
Male
704 Participants
n=99 Participants
101 Participants
n=107 Participants
805 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1748 Participants
n=99 Participants
209 Participants
n=107 Participants
1957 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
Denmark
1748 participants
n=99 Participants
209 participants
n=107 Participants
0 participants
n=206 Participants

PRIMARY outcome

Timeframe: up to 8 year period.

Population: Population

Pubertal onset (according to Tanner stageing - Marshall \& Tanner 1969 and 1970), i.e. Tanner stages B2+ or G2+ \[Tanner stages included genital stages 1-5 as well as pubic hairs tages 1-6\] Data of both arms were pooled for calculation of means.

Outcome measures

Outcome measures
Measure
Cross- Sectional Cohort
n=1748 Participants
Schools were randomly selected and 6203 children (50.0 % girls) were invited to participate (overall participation-rate: 30%). Blood samples were drawn, and a thorough clinical examination was performed in all participating children
Longitudinal Cohort
n=209 Participants
209 healthy Danish children (108 girls), were examined and blood samples were drawn every 6 months.
Pubertal Onset
Girls
9.86 years
Interval 9.7 to 10.01
9.86 years
Interval 9.7 to 10.01
Pubertal Onset
Boys
11.66 years
Interval 11.49 to 11.82
11.66 years
Interval 11.49 to 11.82

Adverse Events

Population

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Anders Juul

Rigshospitalet

Phone: +45 3545 5085

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place